How can liver cancer patients arrange their diet scientifically? Introduction to scientific dietary principles for liver cancer

Scientific dietary principles for liver cancer

As liver cancer continues to worsen, the patient's appetite will become worse and worse, and the patient's digestive system function will gradually weaken. A scientific diet for liver cancer is needed to allow liver cancer patients to eat more, which is beneficial to the condition. So what are the common dietary points for liver cancer? Let the experts tell you about the common dietary points for liver cancer.

In general, the common dietary points for liver cancer are:

Generally speaking, this disease will cause damage to the patient's liver function. In addition, various gastrointestinal symptoms will also appear. Therefore, the diet for liver cancer needs to ensure that the food is easy to digest. Do not eat too hot or too cold food, and do not eat crude fiber food and too hard food to ensure normal digestion and absorption of the gastrointestinal tract.

Low in fat and protein

In daily life, patients often experience symptoms such as indigestion and nausea. Eating too much high-fat food will aggravate these symptoms. Therefore, the diet for liver cancer needs to be light. Since patients eat less, they also need to increase the calories of food. In addition, they need to properly control protein intake to avoid hepatic encephalopathy.

Vitamin supplements

Having enough vitamins in the body can often effectively fight cancer. Therefore, people with liver cancer should eat more foods containing vitamins. For example, vitamin A, vitamin B and vitamin C have anti-cancer effects. Therefore, patients need to eat more fresh vegetables and fruits containing vitamins. Carotene can be converted into vitamin A after entering the human body. Patients can also eat more foods containing carotene.

The above is the common dietary points for liver cancer, I hope it will be helpful to everyone. If you have any questions about the diet for liver cancer, you can contact our online experts, they will give you detailed answers.

Advantages and disadvantages of transcatheter arterial chemoembolization after liver cancer surgery

Whether liver cancer patients relapse after liver resection seriously affects the long-term survival rate of patients. Hepatic artery chemoembolization is a major measure to prevent liver cancer recurrence in patients after liver cancer resection.

The reason why hepatic artery chemoembolization after liver cancer resection can prevent liver cancer recurrence is that hepatic artery angiography should be performed at the same time as hepatic artery chemoembolization, and hepatic artery angiography is very sensitive to diagnosing whether there are tiny liver cancer metastatic lesions in the remaining liver after surgery, and can usually detect lesions with a diameter of 5mm. Arterial chemoembolization can kill these lesions, thereby reducing the possibility of postoperative recurrence in liver cancer patients. However, arterial chemoembolization can also damage liver function. If there are tiny metastatic lesions remaining in the remaining liver, then chemoembolization will not play a role in preventing and treating recurrence. On the contrary, excessive and repeated chemoembolization will damage liver function and affect the patient's long-term survival.

It can be said that there are advantages and disadvantages to performing hepatic artery embolization chemotherapy on patients with liver cancer after resection. However, so far, there is no method that is effective and has no side effects in preventing and treating recurrence.

Therefore, hepatic artery chemoembolization should be selectively used for patients with liver cancer after surgery. Patients with a high risk of recurrence after surgery, such as those with large tumors (diameter greater than 5 cm), multiple tumors, or vascular invasion (cancer thrombi in portal vein branches or vascular invasion found under a microscope), should be given auxiliary hepatic artery chemoembolization; patients with small liver cancer, no vascular invasion, and severe liver cirrhosis are not suitable for hepatic artery chemoembolization.